Institutional Biosafety Committee (IBC) Services Info Sheet
Advarra’s IBC services offer rapid, flexible solutions for IBC review, especially critical for gene therapy and other high-stakes research.
Advarra’s IBC services offer rapid, flexible solutions for IBC review, especially critical for gene therapy and other high-stakes research.
Advarra’s Institutional Review Board (IRB) offers expert guidance, supporting more than 3,500 institutions, academic medical centers, and site networks.
Secure independent evaluation and adjudication of complex clinical trial endpoints.
Leverage Advarra’s expertise in Canada as the only officially recognized IRB/REB, offering extensive site reach and top-notch research ethics services.
As the research community’s preferred sIRB partner, we help you meet regulatory requirements with efficiency and transparency.
Advarra provides accelerated review timelines, specialized support, and intuitive technology tailored to early phase studies.
Advarra University offers a vast catalog of engaging training solutions tailored to research professionals.
Advarra’s GTR Site Network includes 1,500+ vetted sites worldwide, fully prepared to support clinical trials in genetic engineering and advanced therapies.
Advarra’s eSource and EDC Study Design service provides expert support in building protocol calendars and case report forms.
Site Technology Advarra Cloud Automate, connect, and expedite processes across the clinical trial lifecycle. Advarra Cloud is a next-generation platform
Advarra’s eConsent system is designed to enhance participant engagement while ensuring regulatory compliance through 21 CFR Part 11 standards.
Leverage the only Research Evaluation System designed with guidance from the National Cancer Institute (NCI) and the National Institutes of Health (NIH).